Home/Filings/4/0001127602-24-014269
4//SEC Filing

DeLuca Richard R. 4

Accession 0001127602-24-014269

CIK 0000310158other

Filed

May 5, 8:00 PM ET

Accepted

May 6, 4:08 PM ET

Size

9.5 KB

Accession

0001127602-24-014269

Insider Transaction Report

Form 4
Period: 2024-05-04
DeLuca Richard R.
EVP&Pres, Merck Animal Health
Transactions
  • Exercise/Conversion

    Common Stock

    2024-05-04$127.51/sh+27,126$3,458,836163,719.559 total
  • Tax Payment

    Common Stock

    2024-05-04$127.51/sh13,360$1,703,534150,359.559 total
  • Exercise/Conversion

    Restricted Stock Unit

    2024-05-0427,1260 total
    From: 2024-05-04Exp: 2024-05-04Common Stock (27,126 underlying)
Holdings
  • Common Stock - 401(k) Plan

    (indirect: By 401(k))
    1,236.602
Footnotes (4)
  • [F1]Holdings include shares acquired in dividend reinvestment transactions.
  • [F2]Includes shares acquired and dividends earned through April 5, 2024 in the Merck U.S. Savings Plan, a 401(k) plan.
  • [F3]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
  • [F4]These restricted stock units vested and were distributed as shares of Merck & Co., Inc. common stock in one installment on 5/4/2024.

Issuer

Merck & Co., Inc.

CIK 0000310158

Entity typeother

Related Parties

1
  • filerCIK 0001421339

Filing Metadata

Form type
4
Filed
May 5, 8:00 PM ET
Accepted
May 6, 4:08 PM ET
Size
9.5 KB